共 50 条
[3]
David Olagnier,John Hiscott.Type I and type III interferon‐induced immune response: It's a matter of kinetics and magnitude[J].Hepatology,2014(4)
[4]
Mohamad S. Hakim,Michelle Spaan,Harry L. A. Janssen,Andre Boonstra.Inhibitory receptor molecules in chronic hepatitis B and C infections: novel targets for immunotherapy?[J].Rev. Med. Virol.,2014(2)
[5]
Malcolm J. Macartney,Dianne Irish,Simon H. Bridge,Ana Garcia-Diaz,Clare L. Booth,Adele L. McCormick,Wendy Labbett,Colette Smith,Carmen Velazquez,Sudeep Tanwar,Paul Trembling,Michael Jacobs,Geoff Dusheiko,William Rosenberg,Tanzina Haque.Telaprevir or boceprevir based therapy for chronic hepatitis C infection: Development of resistance-associated variants in treatment failure[J].Antiviral Research,2014
[6]
Donald B. Smith,Jens Bukh,Carla Kuiken,A. Scott Muerhoff,Charles M. Rice,Jack T. Stapleton,Peter Simmonds.Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource[J].Hepatology,2014(1)
[7]
Abu S. Abdul-Quader,Jonathan Feelemyer,Shilpa Modi,Ellen S. Stein,Alya Briceno,Salaam Semaan,Tara Horvath,Gail E. Kennedy,Don C. Des Jarlais.Effectiveness of Structural-Level Needle/Syringe Programs to Reduce HCV and HIV Infection Among People Who Inject Drugs: A Systematic Review[J].AIDS and Behavior,2013(9)
[9]
Giuseppe Sautto,Alexander W. Tarr,Nicasio Mancini,Massimo Clementi,Roberto Burioni.Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies[J].<journal-title>Clinical and Developmental Immunology,2013
[10]
Mark AA Claassen,Harry LA Janssen,André Boonstra.Role of T cell immunity in hepatitis C virus infections[J].Current Opinion in Virology,2013